they are making great progress and the share price gains (not to mention the oppies doubling this week) shows that there is quiet accumulation going on ...
imv it's not going to be too much longer before this breaks out on volume. tightly held by the backers and the long lead time to sales is almost at an end.
marketing effort is being ramped up and the resmed execs they have on board now have the contacts to reallly drive the take up for the three ksx offerings. bear in mind resmed built a billion dollar business from one product in the respitory market.
compnay has said they will release in a short time frame some revenue modelling for asia pacfic region. i suspect this will be the catalyst for a further re-rating as the market takes in the implications of just how big the sales going forward will be.
won;t happen overnight, but could bust into double figures within a matter of months imv. oppies look pretty cheap with a 16 month timeline.
research will reward here ....
KSX Price at posting:
3.4¢ Sentiment: Buy Disclosure: Held
